Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Stocks to be thankful for

Stock reports have resembled an out-of-control traffic light on a race track this week; one day it’s all green, the next, a line of red.It can be hard to know when to make a move when every day...
Jonathon Brown | October 6, 2022 |

Biotech 'Thinking Several Steps Ahead with Optimizing IVR Quality Control

The company's latest science, presented at a recent conference, is discussed in a ROTH Capital Partners report. In a July 31 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that Daré Bioscience Inc. (DARE:NASDAQ) presented two posters o...
Streetwise Reports | August 6, 2019 |

F Disrespectful Fiduciary Responsibility

Concerned under the existential dread that "The robots could take over" and take control of the job of writer as easily as they did to that of the cashier or comedian, I attempted to create an article via an AI algoritm, the result .... There has been a lot of talk in the...
According to published reports | May 6, 2021 |

The Right Tools at the Right Time to Control Crop Disease & Boost Yields

Download the episode here . Agri-tech Company Bee Vectoring Technologies International Inc. ( TSX-V: BEE , OTCQB: BEVVF , Forum ) has pioneered a unique and natural precision agriculture system that uses commercially-grown bees to deliver biological crop ...
Stockhouse Media | July 16, 2020 |

Transenterix Shares Trade Up 25% on FDA Filing for First Machine Vision System in Robotic Surgery

Shares of Transenterix opened 50% higher after the company reported that it has submitted a 510(k) submission to the FDA for the first machine vision system for use in robotic surgery. This morning, medical device company TransEnterix Inc. (TRXC:NYSE.American) , whic...
Streetwise Reports | January 15, 2020 |

Buzz on the Bullboards: Of interest rates and rebates

Inflation continues to surge out of control to the point where grocery rebates seem to offer little help to struggling Canadians. This holiday-shortened week, markets are adjusting to the U.S. Federal Reserve’s move to raise interest rates. Investors a...
Jonathon Brown | July 6, 2023 |

Fed to Tank Dollar - And Will Not Save the Stock Market

Technical analyst Clive Maund discusses moves by the Fed and what they might mean for the U.S. dollar and precious metals. It is measure of how fragile and precarious the situation is that the moment the markets looked like they were on the verge of cras...
Streetwise Reports | June 11, 2019 |

Rally ahead for Molycorp (MCP) and rare earth stocks?

Rare earth stocks such as Molycorp ( NYSE: MCP , Stock Forum ) were all the rage with investors in early 2011. The Market Vectors Rare Earths Strategic Metals ETF ( AMEX: REMX , Stock Forum ) hit its 52-week high of $28.91 per share in April. Molycorp stock, included ...
Justin Dove | October 28, 2012 |

Biotech's New Mesothelioma Trial Data Show Efficacy, Immunogenicity

These results of a study evaluating Targovax's lead candidate are reviewed and commented on in an H.C. Wainwright & Co. report. In a June 22 research note, H.C. Wainwright & Co. analyst Joseph Pantginis reported that Targovax ASA's (TRVX:OSE) ONCOS-102, in trial ...
Streetwise Reports | June 25, 2020 |

The Potential for a Stock Rebound

Yesterday’s session in stocks was a true bloodbath that extended well into today’s overnight sessions. It offered two glimmers of hope: one very temporary that came shortly after we exited our tremendously profitable short position, and the othe...
Monica Kingsley | March 13, 2020 |
1 2 3 4 5 6 7 8 9 10 ...